Company Profile
Luminex
Company Overview
Luminex (NASDAQ:LMNX) is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers.
In October 2015, Luminex received FDA approval for the ARIES® System, a sample to answer system designed to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today's lean laboratory environment. The ARIES® System is the most powerful and intuitive of any sample to answer solution and provides control of the testing process, from accession of the sample to results reporting.
Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research, and food safety.
Notable Products / Brands
FLEXMAP, MAGPIX, ARIES